Company news
Xiamen Amoytop Biotech Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Progress in Repurchasing Shares
November 2, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Not Revising the Conversion Price of "Amoytop Convertible Bonds" Downward
November 2, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on External Donations
November 2, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Indicative Announcement on "Amoytop Convertible Bonds" Expected to Meet Conditions for Revising Conversion Price
October 26, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Report for Q3 2026
October 22, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Voluntary Commitment by Shareholder Holding More Than 5% of the Shares Not to Reduce Shareholdings in the Company
October 22, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Voluntary Commitment by Actual Controllers and Person Acting in Concert Not to Reduce Shareholdings in the Company
October 22, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Progress of Joint Investment with Related Parties and Related Party Transactions
October 22, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Risk Warning Announcement on the Suitability Requirements for Convertible Bond Investors
October 12, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Progress in Repurchasing Shares
October 8, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Satisfaction of Vesting Conditions for the Second Vesting Period of the Initial Grant and the First Vesting Period of the Reserved Grant under the 2024 Restricted Share Incentive Plan
September 29, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors
September 29, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Cancellation of Certain Granted but Unvested Restricted Shares under the 2024 Restricted Share Incentive Plan
September 29, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Adjustment of the Grant Price under the 2024 Restricted Share Incentive Plan
September 29, 2026
(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Adding Implementation Locations for Certain Raised Funds Investment Projects Financed by Convertible Corporate Bonds
September 29, 2026
Announcement on Change of Board Secretary
September 29, 2026
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026
September 28, 2026
Announcement on Joint Investment with Related Parties and Related Party Transactions
September 11, 2026
Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
September 7, 2026
Announcement on Use of Funds Raised from Convertible Corporate Bonds to Replace Self-raised Funds Previously Invested in Raised Funds Investment Projects and Paid Issuance Expenses
August 18, 2026
Announcement on Opening a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement for Deposit of Raised Funds in Special Account
August 13, 2026
Announcement on Listing of Convertible Corporate Bonds Issued to Unspecified Investors
August 10, 2026
Indicative Announcement on Results of Issuance of Convertible Corporate Bonds to Unspecified Investors
August 2, 2026
Announcement on Online Balloting Results for the Public Offering of Convertible Corporate Bonds to Unspecified Investors
July 29, 2026
Announcement on Online Subscription Success Rate and Priority Placement Results for the Public Offering of Convertible Bonds to Unspecified Investors
July 28, 2026
Indicative Announcement on Issuance of Convertible Corporate Bonds to Unspecified Investors
July 27, 2026
Announcement on the Online Roadshow for the Issuance of Convertible Corporate Bonds to Unspecified Investors
July 23, 2026
Voluntary Disclosure Announcement on ACT201 Injection Obtaining Notice of Approval for Drug Clinical Trial
July 15, 2026
Announcement on Progress in Repurchasing Shares
July 1, 2026
Announcement on Obtaining Registration Approval of Application for Issuing Convertible Corporate Bonds to Non-specific Objects from China Securities Regulatory Commission
June 25, 2026
Announcement on Repurchasing 2% Shares through Call Auction and Progress in Repurchasing Shares
June 17, 2026
Announcement on Voluntary Disclosure on the Acceptance Notification of Clinical Trial Application for ACT201 Injection
June 10, 2026
Announcement on Repurchasing 1% Shares through Call Auction and Progress in Repurchasing Shares
June 3, 2026
Announcement on Initially Repurchasing Shares through Call Auction and Progress in Repurchasing
June 1, 2026
Announcement on Adjusting Upper Limit of Share Repurchase Price after Implementation of Dividend Distribution for 2025
May 29, 2026
Announcement on Application for Issuance of Convertible Corporate Bonds to Non-specific Objects Approved by the Listing Review Committee of Shanghai Stock Exchange
May 26, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 22, 2026
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase
May 15, 2026
Announcement on Resolutions of the 20th Meeting of the 9th Board of Directors
May 11, 2026
Announcement on Progress and Implementation Result of Shares Repurchase and Share Changes
May 8, 2026
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
May 7, 2026
Indicative Announcement on Reply to Review and Inquiry Letter of Issuance of Convertible Corporate Bonds by the Company to Non-specific Objects and Update of Application Documents such as Prospectus
May 6, 2026
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
April 29, 2026
Report for Q1 2026
April 28, 2026
Announcement on Acceptance of Application for Issuing Convertible Corporate Bonds to Non-specific Objects by Shanghai Stock Exchange
April 24, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
April 22, 2026
Announcement on Initially Repurchasing the Company's Shares through Call Auction
April 17, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
April 13, 2026
Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing
April 2, 2026
Notice on Convening the 2025 Annual General Meeting
April 1, 2026